Challenge To Dementia Drug Ruling
The Government’s health watchdog faces court action over its decision to deny tens of thousands of patients access to dementia drugs. Companies involved in the marketing of one of the drugs said they had no option but to seek a judicial review of how the National Institute for Health and Clinical Excellence (Nice) reached its conclusions.
Read More